FDA approves Sarepta’s updated Elevidys label for DMD
The updated Elevidys label now carries a boxed warning regarding the risk of acute liver failure and injury.
Cytiva Navigating cell therapy WP 4
FDA unveils new pathway to usher bespoke therapies to market
Lyell acquires worldwide rights from ICT to CAR T-cell therapy
Eli Lilly keeps up ophthalmic gene therapy push with $475m MeiraGTx deal
FDA halts uniQure’s plans for Huntington’s disease gene therapy
Helex secures $3.5m to advance kidney disease therapies
Eli Lilly buys Adverum in eye disease gene therapy punt
Galapagos to shutter cell and gene therapy unit
